{
  "id": "cluster_2_doc4",
  "content": "Midwest Pediatric Epilepsy Consortium study #MPEC-23-108 tracks 8 patients on combined cannabidiol/fenfluramine regimen. Participant KV (age 12) achieved 58% seizure reduction. Next monitoring appointment scheduled 09/30/2023 at UIHC's Level 4 Epilepsy Center.",
  "metadata": {
    "format": "research_note"
  }
}